comparemela.com

Page 3 - Hossein Borghaei News Today : Breaking News, Live Updates & Top Stories | Vimarsana

AMGEN DATA AT WCLC 2022 HIGHLIGHTS POTENTIAL TO DELIVER TRANSFORMATIVE MEDICINES FOR HISTORICALLY DIFFICULT-TO-TREAT LUNG CANCERS

/PRNewswire/ Amgen (NASDAQ: AMGN) today announced three new data sets from its thoracic oncology portfolio that will be presented at the International.

Shared decision-making required when choosing first-line regimen for PD-L1-high NSCLC

CHICAGO — Chemoimmunotherapy and immunotherapy alone conferred comparable benefit as first-line therapy for most patients with advanced non-small cell lung cancer and high PD-L1 expression, results presented at ASCO Annual Meeting showed.Older patients appeared to derive better OS and PFS outcomes with immunotherapy alone, findings from the exploratory pooled analysis showed.

CURE Media Group Announces 2021 Lung Cancer Heroes® Award Winners

CURE Media Group Announces 2021 Lung Cancer Heroes® Award Winners
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

CURE Media Group Announces 2021 Lung Cancer Heroes® Award Winners

CURE Media Group Announces 2021 Lung Cancer Heroes® Award Winners
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

GO2 Foundation for Lung Cancer Expands Scientific Leadership Board in Effort to Double Five-Year Survival Rate by 2025

GO2 Foundation for Lung Cancer Expands Scientific Leadership Board in Effort to Double Five-Year Survival Rate by 2025
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.